ASX - By Stock
|
VIT |
Re:
How we value CAU
|
|
sidage
|
19 |
64K |
5 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
19
|
64K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Meets Primary Endpoints for Insomnia Trial
|
|
sidage
|
268 |
200K |
1 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
268
|
200K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Meets Primary Endpoints for Insomnia Trial
|
|
sidage
|
268 |
200K |
7 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
268
|
200K
|
7
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Meets Primary Endpoints for Insomnia Trial
|
|
sidage
|
268 |
200K |
4 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
268
|
200K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
IPO - Emerald Clinics Limited
|
|
sidage
|
57 |
171K |
1 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
57
|
171K
|
1
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
1 |
16/02/20 |
16/02/20 |
ASX - By Stock
|
30
|
340K
|
1
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
5 |
16/02/20 |
16/02/20 |
ASX - By Stock
|
30
|
340K
|
5
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
1 |
16/02/20 |
16/02/20 |
ASX - By Stock
|
30
|
340K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
CAU is massively overvalued
|
|
sidage
|
17 |
33K |
1 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
17
|
33K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
CAU is massively overvalued
|
|
sidage
|
17 |
33K |
1 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
17
|
33K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
CAU is massively overvalued
|
|
sidage
|
17 |
33K |
3 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
17
|
33K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
CAU is massively overvalued
|
|
sidage
|
17 |
33K |
0 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
17
|
33K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
CAU is massively overvalued
|
|
sidage
|
17 |
33K |
2 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
17
|
33K
|
2
|
|
ASX - By Stock
|
CAN |
Re:
What are we waiting for ?
|
|
sidage
|
95 |
81K |
2 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
95
|
81K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
IPO - Emerald Clinics Limited
|
|
sidage
|
57 |
171K |
3 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
57
|
171K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
IPO - Emerald Clinics Limited
|
|
sidage
|
57 |
171K |
1 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
57
|
171K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
IPO - Emerald Clinics Limited
|
|
sidage
|
57 |
171K |
2 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
57
|
171K
|
2
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
7 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
30
|
340K
|
7
|
|
ASX - By Stock
|
EMD |
30% down in first 2 days of trading
|
|
sidage
|
0 |
4.3K |
0 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
0
|
4.3K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
IPO - Emerald Clinics Limited
|
|
sidage
|
57 |
171K |
2 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
57
|
171K
|
2
|
|
ASX - By Stock
|
TSN |
Short Runway
|
|
sidage
|
30 |
340K |
5 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
30
|
340K
|
5
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Resignation of COO
|
|
sidage
|
12 |
8.5K |
1 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
12
|
8.5K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Resignation of COO
|
|
sidage
|
12 |
8.5K |
1 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
12
|
8.5K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Secures Institutional Funding Support for Working Capital
|
|
sidage
|
37 |
27K |
6 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
37
|
27K
|
6
|
|
ASX - By Stock
|
ZLD |
Re:
Insomnia annoucement how far off??
|
|
sidage
|
63 |
44K |
3 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
63
|
44K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Insomnia annoucement how far off??
|
|
sidage
|
63 |
44K |
3 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
63
|
44K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Successfully Completes Capital Raising of $4.6M
|
|
sidage
|
46 |
23K |
8 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
46
|
23K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Successfully Completes Capital Raising of $4.6M
|
|
sidage
|
46 |
23K |
3 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
46
|
23K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
sidage
|
31 |
19K |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
31
|
19K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
sidage
|
31 |
19K |
1 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
31
|
19K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
42 |
29K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
42
|
29K
|
1
|
|
ASX - By Stock
|
IRX |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
11 |
8.0K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
11
|
8.0K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
News: CAU Cronos Australia Buys 51% Stake In Cannadoc Health Pty. Ltd
|
|
sidage
|
2 |
2.1K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
2
|
2.1K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
sidage
|
31 |
19K |
3 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
31
|
19K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to Collaborate with the Parkinsons Foundation
|
|
sidage
|
50 |
38K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
50
|
38K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
42 |
29K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
42
|
29K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
42 |
29K |
1 |
02/02/20 |
02/02/20 |
ASX - By Stock
|
42
|
29K
|
1
|
|
ASX - By Stock
|
ZLD |
Has Zelda given us a 50% dilution to buy a company which was only worth $435,000?
|
|
sidage
|
6 |
3.2K |
1 |
02/02/20 |
02/02/20 |
ASX - By Stock
|
6
|
3.2K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: THC Global Quarterly Update & Appendix 4C
|
|
sidage
|
59 |
38K |
1 |
01/02/20 |
01/02/20 |
ASX - By Stock
|
59
|
38K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
8 |
6.0K |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
8
|
6.0K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
sidage
|
7 |
3.9K |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
7
|
3.9K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
8 |
6.0K |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
8
|
6.0K
|
1
|
|
ASX - By Stock
|
IRX |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
11 |
8.0K |
0 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
11
|
8.0K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
42 |
29K |
0 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
42
|
29K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
8 |
6.0K |
2 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
8
|
6.0K
|
2
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
42 |
29K |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
42
|
29K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Cap raise coming on back of 4C
|
|
sidage
|
17 |
12K |
3 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
17
|
12K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
sidage
|
7 |
5.3K |
2 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
7
|
5.3K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Appendix 4C - quarterly
|
|
sidage
|
10 |
7.3K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
10
|
7.3K
|
0
|
|
ASX - By Stock
|
HGV |
Re:
which of the MMJ investments are doing well and which are doing badly?
|
|
sidage
|
11 |
8.4K |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
11
|
8.4K
|
1
|
|